eversyn

Description: eversyn develops GMO-free biocatalytic tech to produce affordable nucleotide sugars, human milk oligosaccharides, and glycosylated therapeutic proteins.

Country: Germany

Based in: Magdeburg

Founded: 2022

Funding Stage: Pre-Seed

Tags: ['Synthetic Glycobiotechnology', 'Glycobiotechnology', 'Biotechnology', 'Oligosaccharides', 'Nucleotide Sugars']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.